Title : Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation.

Pub. Date : 2015 Apr

PMID : 25874518






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Azathioprine discontinuation earlier than 6 months in Crohn"s disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. Azathioprine tumor necrosis factor Homo sapiens
2 Azathioprine discontinuation earlier than 6 months in Crohn"s disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. Azathioprine tumor necrosis factor Homo sapiens
3 Factors associated with loss of response and therefore the need for anti-TNF dose escalation were azathioprine discontinuation earlier than 6 months and smoking. Azathioprine tumor necrosis factor Homo sapiens
4 CONCLUSION: Azathioprine discontinuation earlier than 6 months and smoking in CD patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. Azathioprine tumor necrosis factor Homo sapiens
5 CONCLUSION: Azathioprine discontinuation earlier than 6 months and smoking in CD patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation. Azathioprine tumor necrosis factor Homo sapiens